Canagliflozin (Invokana, Janssen) improved renal outcomes and demonstrated potential renal protective effects, according to additional analyses from the CANVAS clinical trial presented at the American Society of Nephrology Kidney Week 2017 Annual Meeting.
Rigorous screening guidelines can reduce the number of undiagnosed cases of diabetes.
Top articles of the week from The American Journal of Pharmacy Benefits.
Low brain glucose levels may result in overeating among patients with obesity and type 2 diabetes.
Pregnant women who slept less than 6.5 hours per night were nearly 3 times as likely to develop gestational diabetes.
Top news of the day from across the healthcare landscape.
Top news of the day from across the healthcare landscape.
Deleting fatty acid-binding proteins may lead to lifelong metabolic health.
Which OTC products should these pharmacists recommend?
Researchers have augmented insulin’s effectiveness with several rapid and long-acting analogs and new delivery systems, such as insulin pens and insulin pumps.
The number of diabetes cases continues to soar, with the latest data showing that an estimated 30.3 million Americans have the disease.
The increasing incidence of diabetes is outpacing the number of health care providers skilled in caring for affected patients.
PPARγ agonists may improve outcomes for patients with acute myeloid leukemia.
Patients treated with Bydureon BCise had an average HbA1c reduction of 1.4% after 28 weeks.
Antibiotics were previously thought to increase the incidence of certain autoimmune diseases.
Top articles of the week from The American Journal of Pharmacy Benefits.
A ketogenic state may provide benefits for patients with diabetes.
Once-weekly injection of semaglutide recommended for approval for improved glycemic control in adults with type 2 diabetes.
Officials with Novo Nordisk have announced that the FDA's Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) voted 16-0, supporting the approval of once-weekly semaglutide to improve glycemic control in adults with type 2 diabetes.
This year, the FDA is on pace to approve about 38 new medications. Here is a look at 5 of those.
Better medication adherence may not result in lower short-term medical costs for patients with diabetes.
Pharmacists are uniquely suited helping patients figure out the optimal therapies for their diabetes.
Stress, food, lack of water, and other issues impact the body's physiology, and pharmacists can counsel patients to adjust these issues to live healthier lives.
Enzymes that activate blood vessel formation crucial for wound healing.
The National Clinical Care Commission Act would better coordinate diabetes research.
